Dr Tamara Cooper

Dr Tamara Cooper

Senior Research Fellow

School of Pharmacy and Biomedical Sciences

College of Health

Eligible to supervise Masters and PhD as Co-Supervisor only - email supervisor to discuss availability.

Year Citation
2026 Vijayan, A., Cooper, T., Kolfschoten, M. V. D. N., Heinemann, G., Van Kampen, M., Boedhoe, S., . . . Vogels, R. (2026). Heterologous vaccination with a next-generation vaccinia virus and Ad26 induces Ebola-specific immunity in macaques. Npj Vaccines, 11(1), 11 pages.
DOI
2024 Wang, S., Qiao, X., Cui, Y., Liu, L., Cooper, T., Hu, Y., . . . Wang, X. (2024). NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling. Cell Death and Disease, 15(8), 16 pages.
DOI Scopus17 WoS17 Europe PMC17
2022 Eldi, P., Cooper, T. H., Prow, N. A., Liu, L., Heinemann, G. K., Zhang, V. J., . . . Hayball, J. D. (2022). The vaccinia-based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses. Immunology and Cell Biology, 100(4), 250-266.
DOI Scopus5 WoS5 Europe PMC3
2020 Nguyen, W., Nakayama, E., Yan, K., Tang, B., Le, T. T., Liu, L., . . . Suhrbier, A. (2020). Arthritogenic alphavirus vaccines: serogrouping versus cross-protection in mouse models. Vaccines, 8(2), 209-1-209-26.
DOI Scopus38 WoS38 Europe PMC43
2020 Prow, N. A., Liu, L., McCarthy, M. K., Walters, K., Kalkeri, R., Geiger, J., . . . Suhrbier, A. (2020). The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. NPJ Vaccines, 5(1, article no. 44), 44-1-44-10.
DOI Scopus23 WoS19 Europe PMC19
2020 Wang, M., Qiao, X., Cooper, T., Pan, W., Liu, L., Hayball, J., . . . Wang, X. (2020). HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Cell Death and Disease, 11(12, article no. 1049), 1-16.
DOI Scopus37 WoS41 Europe PMC42
2019 Eldi, P., Cooper, T., Ward, M., & Hayball, J. D. (2019). How emerging vaccine technologies are pushing disease prevention boundaries. International pharmacy journal, 37(1), 16-19.
2018 Prow, N., Liu, L., Nakayama, E., Cooper, T., Yan, K., Eldi, P., . . . Suhrbier, A. (2018). A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Nature Communications, 9(1), 1230-1-1230-12.
DOI Scopus75 WoS72 Europe PMC72
2017 Liu, L., Cooper, T., Eldi, P., Garcia-Valtanen, P., Diener, K., Howley, P., & Hayball, J. (2017). Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from Vaccinia virus. BioTechniques, 62(4), 183-187.
DOI Scopus4 WoS4 Europe PMC4
2017 Eldi, P., Cooper, T., Liu, L., Prow, N., Diener, K., Howley, P., . . . Hayball, J. (2017). Production of a chikungunya vaccine using a CHO cell and attenuated viral-based platform technology. Molecular Therapy, 25(10), 2332-2344.
DOI Scopus20 WoS20 Europe PMC20
2014 Liu, L., Cooper, T., Howley, P., & Hayball, J. (2014). From crescent to mature virion: vaccinia virus assembly and maturation. Viruses, 6(10), 3787-3808.
DOI Scopus58 WoS48 Europe PMC49
2013 Siddiqui, M., Filomeni, E., Francois, M., Collins, S., Cooper, T., Glatz, R., . . . Leifert, W. (2013). Exposure of insect cells to ionising radiation in vivo induces persistent phosphorylation of a H2AX homologue (H2AvB). Mutagenesis, 28(5), 531-541.
DOI Scopus11 WoS12 Europe PMC8
2011 Cooper, T., Bailey-Hill, K., Leifert, W., McMurchie, E., Asgari, S., & Glatz, R. (2011). Identification of an in vitro interaction between an insect immune suppressor protein (CrV2) and Gα proteins. Journal of Biological Chemistry, 286(12), 10466-10475.
DOI Scopus13 WoS11 Europe PMC7
2010 Leifert, W. R., Glatz, R. V., Bailey, K., Cooper, T., Bally, M., Stadler, B. M., . . . Shapter, J. G. (2010). Nanoscale biosensors and biochips. Annual Review of Nano Research, 3, 1-82.
DOI Scopus5
2009 Cooper, T., McMurchie, E., & Leifert, W. (2009). [³⁵S]GTPγS binding in G protein-coupled receptor assays. Methods in Molecular Biology, 552, 143-151.
DOI Scopus4 Europe PMC4
2008 Cooper, T., Leifert, W., Glatz, R., & McMurchie, E. (2008). Expression and characterisation of functional lanthanide-binding tags fused to a Galpha-protein and muscarinic (M2) receptor. Journal of Bionanoscience, 2(1), 27-34.
DOI Scopus2
2008 Cooper, T. H. J., Leifert, W., Glatz, R. V., & McMurchie, E. J. (2008). Expression and characterisation of functional lanthanide-binding tags fused to a Ga-protein and muscarinic (M2) receptor. Journal of Bionanoscience, 2(1), 27-34.
DOI
2007 Glatz, R., Leifert, W., Cooper, T., Hill, K., Barton, C., Martin, A., . . . McMurchie, E. (2007). Molecular engineering of G protein-coupled receptors and G proteins for cell-free biosensing. Australian Journal of Chemistry, 60(5), 309-313.
DOI Scopus4 WoS3
2006 Leifert, W., Hill, K., Cooper, T., Aloia, A., Glatz, R., & McMurchie, E. (2006). Measurement of heterotrimeric G-protein and regulators of G-protein signaling interactions by time-resolved fluorescence resonance energy transfer. Analytical Biochemistry, 355(2), 201-212.
DOI Scopus20 WoS23 Europe PMC16

Year Citation
2010 Leifert, W. R., Cooper, T. H., & Bailey, K. (2010). G-protein coupled receptors: progress in surface display and biosensor technology. In B. Bhushan, & B. B. (Eds.), Source details - Title: Springer handbook of nanotechnology (pp. 485-501). Germany: Springer.
DOI
2009 Cooper, T., McMurchie, E. J., & Leifert, W. R. (2009). [<SUP>35</SUP>S]GTPĪ³S Binding in G Protein-Coupled Receptor Assays. In W. R. Leifert (Ed.), G PROTEIN-COUPLED RECEPTORS IN DRUG DISCOVERY (Vol. 552, pp. 143-151). HUMANA PRESS INC.
DOI WoS4

Year Citation
2017 Eldi, P., Cooper, T., Liu, L., Howley, P., Smith, W., & Hayball, J. (2017). A NOVEL IMMUNOTHERAPEUTIC VACCINE TO MODULATE CYTOKINE RESPONSES OF ANTIGEN-SPECIFIC CD4<SUP>+</SUP> T CELLS IN PEANUT ALLERGY. In INTERNAL MEDICINE JOURNAL Vol. 47 (pp. 14). WILEY.
DOI
2016 Hayball, J., Liu, L., Cooper, T., Eldi, P., & Howley, P. (2016). SCV platform: a novel replication-incompetent vaccinia viral vaccine vector system. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 1227). AUSTRALIA, Melbourne: WILEY-BLACKWELL.
2016 Hayball, J., Cooper, T., Liu, L., Eldi, P., Tan, M., Prow, N., . . . Howley, P. (2016). A dual Chikungunya and smallpox vaccine derived from a novel, replication-incompetent poxvirus vaccine system provides mice with complete protection from Chikungunya virus and mousepox infection. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 809). AUSTRALIA, Melbourne: WILEY-BLACKWELL.

  • Sementis SCV Vaccine Development Laboratory Reagents and Consumables, Sementis Pty Ltd, 01/01/2026 - 30/06/2026

  • Sementis SCV Vaccine Development Research Fellow Support, Sementis Pty Ltd, 31/12/2025 - 30/06/2026

  • Development of a prototype immunomodulatory vaccine for cat allergy, Sementis Pty Ltd, 02/09/2016 - 19/12/2019

  • Development of a prototype immunomodulatory vaccine for cat allergy, SIEF STEM+ Business Fellowship Program, 02/09/2016 - 02/09/2019

Date Role Research Topic Program Degree Type Student Load Student Name
2020 Co-Supervisor Preclinical evaluation of passive and active immunotherapies for melanoma Doctor of Philosophy Doctorate Full Time Ms Samantha Jane Watson

Date Role Research Topic Program Degree Type Student Load Student Name
2019 - 2021 Co-Supervisor Understanding a novel replication-deficient poxviral-based vector platform Doctor of Philosophy Doctorate Full Time Miss Abigail Trinidad
2018 - 2022 Co-Supervisor Evaluation of antigen-specific immune responses elicited by single and multiple pathogen vaccines designed using a vaccinia virus-based vector system Doctor of Philosophy Doctorate Full Time Miss Fan Jia

Connect With Me

External Profiles

Other Links